Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug Launch Prices According to coverage in STAT News, a recent analysis published in the Journal of the American Medical Association (JAMA) found U.S. Food and Drug Administration (FDA) approved patents secured by Big Pharma are more frequently invalidated than any other industry sector due to
Another Blockbuster Quarter for Profits as Big Pharma Maintains Business-as-Usual Approach to Price Gouging Americans Eli Lilly, GlaxoSmithKline and AstraZeneca rounded out earnings calls for Big…
PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing Larger Oops. Big Pharma accidentally helped debunk one of the myths perpetuated by the pharmaceutical industry this week…
Commission Targets More Than 100 Patents on Brand Name Products Listed in the U.S. Food and Drug Administration’s Orange Book For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]…
Another Series of Strong Earnings Reports For Brand Name Giants Fueled by Egregious Price Increases This week, Big Pharma giant AbbVie and Amgen both held earnings calls for the third quarter where…
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable Drugs Now, Encourage Lawmakers to Boost Competition, Hold Big Pharma Accountable to Lower Drug Prices In case you…
New Analysis Finds Drug Companies Continue to Price-Gouge American Patients, Increase Prices on Brand Name Drugs Used to Treat Serious Conditions An analysis released Wednesday by the Center for…
More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following Price Hikes Earlier In Year As more Big Pharma giants announce third quarter earnings for 2023…
Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and Can Negatively Impact Outcomes for Patients A new paper published by BMJ found that oncologists who received kickback…
Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times This Year This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls…